Publish in this journal
Journal Information
Vol. 75. Issue 5.
Pages 431-439 (May 2022)
Visits
Not available
Vol. 75. Issue 5.
Pages 431-439 (May 2022)
Editor's page
Full text access
New editors, new perspectives
Nuevo equipo editorial, nuevas perspectivas
Visits
...
Juan Sanchisa,
Corresponding author
rec@revespcardiol.org

Corresponding author: Revista Española de Cardiología, Ntra. Sra. de Guadalupe 5, 28028 Madrid, Spain.
, Pablo Avanzasb, David Filgueiras-Ramab, Pablo García-Pavíab, Laura Sanchisb, Iria del Ríoc
a Editor-in-Chief, Revista Española de Cardiología
b Associate Editor, Revista Española de Cardiología
c Editorial Director, Revista Española de Cardiología
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (5)
Table 1. Research articles, reviews, and position papers published in Revista Española de Cardiología in 2018, 2019, 2020, and 2021 with the greatest impact*
Table 2. Articles receiving an award from the Spanish Society of Cardiology in 2021
Table 3. Editorial teams* of Rev Esp Cardiol since its founding in 1947
Table 4. Professionals collaborating as reviewers with Rev Esp Cardiol in 2021
Table 5. Elite reviewers 2021
Show moreShow less
Full Text

A new editorial team for Revista Española de Cardiología (Rev Esp Cardiol) was appointed at the Cardiovascular Disease Congress of October 2021, following the statutory 6-year incumbency of the previous team.1 It is only fitting to begin this “Editor's page” with an acknowledgement of the tremendous work of the previous team. Beyond the peak impact factor (IF) of, 5.166, achieved in 2017, the main accomplishment has been the comfortable consolidation of the IF above 4 (range, 4.485-5.166). The impact of Rev Esp Cardiol is unequivocally illustrated by the progressive growth in external citations, which reached 78% in the last year.2Table 1 shows the articles published in the journal in recent years with the greatest impact while Table 2 lists the articles receiving awards from the Spanish Society of Cardiology in 2021.

Table 1.

Research articles, reviews, and position papers published in Revista Española de Cardiología in 2018, 2019, 2020, and 2021 with the greatest impact*

Year  Title  Type of publication  Total citations 
2018Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVE’, SECOT and AEU3  Position paper  50 
Association Between a Healthy Lifestyle Score and the Risk of Cardiovascular Disease in the SUN Cohort4  Original article  31 
Spanish Cardiac Catheterization and Coronary Intervention Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2017)5  Special article  24 
Spanish Catheter Ablation Registry. 17th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2017)6  Special article  23 
Comparison of the Hemodynamic Performance of the Balloon-expandable SAPIEN 3 Versus Self-expandable Evolut R Transcatheter Valve: A Case-matched Study7  Original article  22 
Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study8  Original article  22 
Tako-tsubo Syndrome in Men: Rare, but With Poor Prognosis9  Original article  20 
2019Recommendations of the Geriatric Cardiology Section of the Spanish Society of Cardiology for the Assessment of Frailty in Elderly Patients With Heart Disease10  Special article  38 
Vasoactive Inotropic Score as a Predictor of Mortality in Adult Patients With Cardiogenic Shock: Medical Therapy Versus ECMO11  Original article  34 
Excess Weight in Spain: Current Situation, Projections for 2030, and Estimated Direct Extra Cost for the Spanish Health System12  Original article  31 
Applications of Artificial Intelligence in Cardiology. The Future is Already Here13  Review  25 
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis14  Original article  24 
High-intensity Interval Training Dosage for Heart Failure and Coronary Artery Disease Cardiac Rehabilitation. A Systematic Review and Meta-analysis15  Original article  21 
Beta-blockers: Historical Perspective and Mechanisms of Action16  Review  21 
Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design17  Original article  21 
2020Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology18  Position paper  59 
Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology19  Position paper  50 
Exercising in times of COVID-19: what do experts recommend doing within four walls?20  Editorial  37 
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience21  Original article  30 
Arterial thrombotic complications in hospitalized patients with COVID-1922  Scientific letter  21 
Prevalence of overweight, obesity and abdominal obesity in the Spanish population aged 3 to 24 years. The ENPE study23  Original article  14 
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study24  Original article  14 
Recommendations to improve lipid control. Consensus document of the Spanish Society of Cardiology25  Position paper  13 
2021Acute myocarditis after administration of the BNT162b2 vaccine against COVID-1926  Scientific letter  21 
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry27  Original article  15 
Spontaneous coronary artery dissection in Spain: clinical and angiographic characteristics, management, and in-hospital events28  Original article  11 
Markers of myocardial injury in the prediction of short-term COVID-19 prognosis29  Original article 
Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center30  Original article 
Integration of artificial intelligence into clinical patient management: focus on cardiac imaging31  Review 
Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart32  Original article 
Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases33  Original article 
Very short dual antiplatelet therapy after PCI and new DES: a meta-analysis of 5 randomized trials34  Original article 
*

Extracted from Web of Science on January 13, 2022; this figure includes citations generated from the publication of each article until December 31, 2021.

Table 2.

Articles receiving an award from the Spanish Society of Cardiology in 2021

1. Prizes awarded by the Spanish Society of Cardiology for articles published inRev Esp Cardiol 
First prize (awarded to 2 articles) Rodríguez-Leor et al. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Esp Cardiol. 2020;73:994–1002. Raposeiras-Roubín et al. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction. Rev Esp Cardiol. 2020;73:114-122. 
Second prize Sánchez-Salado et al. Trends in cardiogenic shock management and prognostic impact of type of treating center. Rev Esp Cardiol. 2020;73:546-553. 
2. Prizes awarded by the Spanish Society of Cardiology for the articles published inRev Esp Cardiolwith the greatest international impact 
Most-cited articles, long-term 
First prize Barrios et al. Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study. Rev Esp Cardiol. 2015;68:769:776
Second prize Barrabés et al. Prognosis and Management of Acute Coronary Syndrome in Spain in 2012: The DIOCLES Study. Rev Esp Cardiol. 2015;68:98-106. 
Most-cited articles, midterm 
First prize Díaz-Gutierrez et al. The Ratio Between Visceral and Subcutaneous Abdominal Fat Assessed by Computed Tomography Is an Independent Predictor of Mortality and Cardiac Events. Rev Esp Cardiol. 2018;71:357-364. 
Second prize (awarded to 3 articles) Amat-Santos et al. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation. Rev Esp Cardiol. 2018;71:357-364.Pérez-Castellanos et al. Tako-tsubo Syndrome in Men: Rare, but With Poor Prognosis. Rev Esp Cardiol. 2018;71:703-708.Enríquez-Rodríguez et al. Comparison of the Hemodynamic Performance of the Balloon-expandable SAPIEN 3 Versus Self-expandable Evolut R Transcatheter Valve: A Case-matched Study. Rev Esp Cardiol. 2018;71:735-742. 
3. Prize awarded by the Spanish Society of Cardiology for the best article published inREC: CardioClinics 
Crespo-Leiro et al. One-year prognosis of patients with heart failure in Spain. ESC-EORP-HFA Heart Failure Long-Term Registry. REC CardioClinics. 2020;55:207-216. 
4. Prizes awarded by the Interventional Cardiology Association for the best articles published inREC: Interventional Cardiology 
First prize Rodríguez-Leor et al. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. REC Interv Cardiol. 2020;2:82-89. 
Second prize Jiménez-Quevedo et al. Time trend in transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry. REC Interv Cardiol. 2020;2:96-105. 
5. Prizes awarded by the Clinical Cardiology Association for the best articles published inRev Esp Cardiol Anguita Sánchez et al. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study. Rev Esp Cardiol. 2020;73:14-20. Díez-Espino et al. Impact of Life's Simple 7 on the incidence of major cardiovascular events in high-risk Spanish adults in the PREDIMED study cohort. Rev Esp Cardiol. 2020;73:205-211. 
6. Prize awarded by the Ischemic Heart Disease and Acute Cardiac Care Association for the best article published inRev Esp Cardiol Sánchez-Salado et al. Trends in cardiogenic shock management and prognostic impact of type of treating center. Rev Esp Cardiol. 2020;73:546-553. 
7. Prize awarded by the Cardiovascular Risk and Rehabilitation Association for the best publication Palau et al. Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction. Rev Esp Cardiol. 2020;73:463-470. 
8. Prize awarded by the Heart Rhythm Association for the best article published inRev Esp Cardiol Jordán-Martínez et al. Atrioventricular block in patients undergoing treatment with bradycardic drugs. Predictors of pacemaker requirement. Rev Esp Cardiol. 2020;73:554-560. 
9. Prize awarded by the Pediatric Cardiology and Congenital Heart Disease Section for the best article published inRev Esp Cardiol Oliver Ruiz et al. Adult congenital heart disease in Spain: health care structure and activity, and clinical characteristics. Rev Esp Cardiol. 2020;73:804-811. 
10. Prize awarded by the Section on Familial Heart Disease and Cardiovascular Genetics for the best article published inRev Esp Cardiol Alonso-Fernández- Gatta et al. A rare HCN4 variant with combined sinus bradycardia, left atrial dilatation, and hypertrabeculation/left ventricular noncompaction phenotype. Rev Esp Cardiol. 2020;74:781-789. 
11. Prize awarded by the Section on Cardiac Pacing on cardiac pacing Moriña-Vázquez et al. Early improvement of leftEarly improvement of left ventricular ejection fraction by cardiac resynchronization through His bundle pacing in patients with heart failure. Europace. 2020;22:125-132. 
12. Ninth Magda Heras prizes for the best article published in an Iberoamerican cardiovascular journal 
First prize Rodríguez-Leor et al. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Esp Cardiol. 2020;73:994-1002. 
Second prize Lonis et al. Cardiac remodeling in experimental cardiac failure induced by hyperlipidemia in mice. Rev Chil Cardiol. 2020;39:24-33. 
Third prize Pérez Zerpa et al. Clinical and etiological profile of patients operated on with active endocarditis. Follow-up at 10 years. Rev Urug Cardiol. 2020;35:169-179. 

For the first time in the history of Rev Esp Cardiol, and on the initiative of the previous team and with the support of the Executive Committee of the Spanish Society of Cardiology, the new Editor-in-Chief was chosen through a competitive process. The new Editor-in-Chief (Juan Sanchis) would like to acknowledge the trust placed in him by the selection committee and the Executive Committee of the Spanish Society of Cardiology to lead the new period of Rev Esp Cardiol. In addition, he would like to highlight the eagerness and enthusiasm of the Associate Editors (Pablo Avanzas, David Filgueiras-Rama, Pablo García-Pavía, and Laura Sanchis) forming the new team. Together, we begin this new era with considerable excitement. With the change in the editorial team in October 2021, Dr Pablo Avanzas became Associate Editor and handed over the management of the social media for REC Publications to Dr Juan Quiles. The competition to select the new Editor-in-Chief in February 2021 enabled the new editorial team to be selected months before the de facto change, which occurred in October 2021. This time has allowed an organized transition that has benefited from the outstanding support of both the previous editorial team and the editorial office. We would like to thank the editorial office of REC Publications, managed by Iria del Río and comprising, additionally, Eva M. Cardenal, María González Nogal, Belén Juan, and Helena Gómez-Lobo, who together form one of the most solid cornerstones upon which Rev Esp Cardiol is built.

In addition, we would like to highlight and acknowledge the work of the translation and proofreading teams. The English-language version continues to rely on an experienced team of professionals, comprising Simon Bartlett, Helen Casas, Celine Cavallo, Kevin Clayton, Simon Coxon, Jane Marshall, Greg Morley, and Anne Murray, with Gail Craigie as copy-editor, who have a long relationship with our journal. The professionalism of our translators, their meticulous work, their attention to detail, and their perceptive comments make a strong contribution to the quality of Rev Esp Cardiol. We would also like to use this opportunity to thank the staff members in charge of our journal in Elsevier, particularly Beatriz Mas, Azucena Saavedra, and Toni Rodríguez, for their work and dedication and to all of the departments at the SEC's headquarters, Casa del Corazón, whose work boosts the visibility of the journal.

75 YEARS AT THE HEART OF CARDIOVASCULAR RESEARCH

In 2022, we celebrate the 75th anniversary of our journal. Table 3 lists the various editorial teams that have managed the journal, from its founding to the current team, and Figure 1 shows an image of the first article, published in 1947. Here, we would like to pay tribute to all of the editors, reviewers, authors, translators, proofreaders, and professionals who have collaborated with Rev Esp Cardiol during these 75 years. As mentioned in the statutes of the Spanish Society of Cardiology, Rev Esp Cardiol is the official scientific publication and institutional vehicle of expression of the Spanish Society of Cardiology. It is defined as an “international journal that publishes scientific articles on cardiovascular diseases”. Undoubtedly, the major advantage of Rev Esp Cardiol is the unconditional support of the Spanish Society of Cardiology and the scientifc community behind it. The quality and speed of the peer reviews is undeniable proof of the commitment to our journal. In the last year, the reviews were conducted with an overall time of 8.7 days (9.9 for original articles). We wish to highlight the dedication of our reviewers at a time in which other journals are struggling to find reviewers for their articles. The combined efforts of all involved have allowed Rev Esp Cardiol to achieve its current privileged situation and we would like to use this opportunity to acknowledge the sterling work of those who collaborate with our journal (Table 4), many without even belonging to our Editorial Committee or Advisory Boards, and we highlight the exceptional work of our elite reviewers (Table 5).

Table 3.

Editorial teams* of Rev Esp Cardiol since its founding in 1947

Year  Editor-in-Chief  Associate Editors 
1947  Antonio Duque Sampayo   
1952  Antonio Duque Sampayo   
1959  José de la Hoz Fabra   
1963  Justo González Álvarez   
1967  Justo González Álvarez   
1971  Francisco Pérez Gómez   
1975  Leandro Plaza Celemín   
1977  Javier Carrillo Kabana  Fermín Bañuelos García 
    Antonio Fuertes García 
1979  Juan Luis Delcán Domínguez  Jesús Almendral Garrote 
    Luis Martínez Elbal 
1982  José Luis López Sendón  José A. Eizaguirre Pérez 
    José M. Oliver Ruiz 
1985  Emilio Marín Huerta  David García Dorado 
    Francisco Fernández Avilés 
1988  Emilio Marín Huerta  David García Dorado 
    Francisco Fernández Avilés 
1991  Francisco Fernández Avilés  Joaquín Alonso Martín 
    Andrés Íñiguez Romo 
1996  Francisco Fernández Avilés  Joaquín Alonso Martín 
    Julián Pérez Villacastín 
1998  Xavier Bosch  Joaquín Alonso Martín 
    Julián Pérez Villacastín 
2001  Xavier Bosch  Fernando Alfonso 
    Julián Pérez Villacastín 
2002  Xavier Bosch  Fernando Alfonso 
    Javier Bermejo 
2004  Fernando Alfonso  Javier Bermejo 
    Javier Segovia 
    Magda Heras 
2009  Magda Heras  Pablo Avanzas 
    Antoni Bayés-Genís 
    Leopoldo Pérez de Isla 
    Juan Sanchis 
2015  Juan Sanchis  Miguel Á. Arias 
    Pablo Avanzas 
    Antoni Bayés-Genís 
    Ignacio Ferreira-González 
    Leopoldo Pérez de Isla 
2015  Ignacio Ferreira-González  Emad Abu-Assi 
    Miguel Á. Arias 
    Pastora Gallego 
    Ángel Sánchez-Recalde 
2021  Juan Sanchis  Pablo Avanzas 
    David Filgueiras-Rama 
    Pablo García-Pavía 
    Laura Sanchis 
*

No information is available on Associate Editors before 1977.

Figure 1.

An image of the first article published in Rev Esp Cardiol, 1947.

(0.77MB).
Table 4.

Professionals collaborating as reviewers with Rev Esp Cardiol in 2021

Cesar Abelleira 
Juan Acosta 
Alejandro Adsuar 
Finn Akerström 
Arístides Alarcón 
Dimpna C. Albert 
Manuel Alcázar 
Josep M. Alegret 
Fernando Alfonso 
Luis Almenar 
Manuel Almendro 
Joaquín Alonso 
Pau Alonso 
Gonzalo L. Alonso-Salinas 
Rafael Alonso-González 
Miguel Álvarez 
Teresa Álvarez 
Jesús Álvarez-García 
Ignacio J. Amat 
Dominick Angiolillo 
Ignasi Anguera 
Manuel P. Anguita 
Eduardo Arana 
Albert Ariza 
Pedro Armario 
Ángel Aroca 
Enrique J. Balbacid 
José Banegas 
Jordi Bañeras 
Alfredo Bardají 
Eduardo Barge 
Gonzalo Barge 
José Barrabés 
Manuel Barreiro 
Roberto Barriales 
Vivencio Barrios 
Teresa Bastante 
Javier Bautista 
Antoni Bayés-Genís 
Víctor Bazán 
J. Luis Bernal 
Vicente Bodí 
Alberto Bouzas 
Marisol Bravo 
Montserrat Bret 
María Brión 
Héctor Bueno 
Ramón Calviño 
Francisco E. Calvo 
David Calvo 
Juan Caro 
Amelia Carro 
José Casasnovas 
José M. Castellano 
Pilar Cejudo 
Marinela Chaparro 
Fernando Civeira 
Marta Cobo 
Andrea Colli 
Luciano Consuegra 
Alberto Cordero 
Félix Coserria 
Juan Cosín-Sales 
Eliecer Coto 
David Couto 
Ignacio Cruz 
Héctor Cubero 
Regina Dalmau 
Tomas Datino 
José A. de Agustín 
Jesús M. de la Hera 
José M. de la Torre-Hernández 
Giovanni Luigi De María 
Javier de Miguel 
Irene R. Dégano 
Mónica Delgado 
Juan F. Delgado 
José F. Díaz 
Leonel Díaz-González 
Jesús Díaz-Gutiérrez 
Elena Díaz-Peláez 
Javier Díez 
Pablo Díez-Villanueva 
David Dobarro 
Adelina Doltra 
Laura Domínguez-Pérez 
Fernando Domínguez 
Laura Dos 
Sonia Eiras 
Carlos Escobar 
Laura Escolà-Vergé 
M. Pilar Escribano 
Alberto Esteban-Fernández 
Vicente Estrada 
Artur Evangelista 
Lorenzo Fácila 
Núria Farré 
Ángel L. Fernández 
José A. Fernández-Díaz 
Covadonga Fernández-Golfín 
Nuria Fernández-Hidalgo 
Ignacio Fernández-Lozano 
José L. Ferreiro 
Queralt Ferrer 
Ángela Flox 
Adolfo Fontenla 
José F. Forteza 
María J. Forteza 
Eduardo Franco 
Xavier Freixa 
María Gallego-Delgado 
Ana García-Álvarez 
Ignacio García-Bolao 
Eulogio J. García-Fernández 
Luis García-Guereta 
Alberto García-Lledó 
Xavier García-Moll 
Rocío García-Orta 
José A. García-Robles 
Carlos García Santos-Gallego 
Bruno García del Blanco 
Juan Gimeno 
Manuel Gómez-Bueno 
Juan J. Gómez-Doblas 
Joan A. Gómez-Hospital 
José González-Costello 
Elvira González-Obeso 
Álvaro González-Rocafort 
José M. González-Santos 
Esteban González-Torrecilla 
Esther González 
Teresa González-Alujas 
Antonio González-Calle 
José González-Juanatey 
Violeta González-Salvado 
Francisco González-Vílchez 
Ferrán Gran 
José Guerra 
Carlos Guijarro 
Encarnación Gutiérrez-Carretero 
Enrique Gutiérrez-Ibañes 
Gabriela Guzmán-Martínez 
Ramón Hermida 
Felipe Hernández-Hernández 
Rocío Hinojar 
Ignacio Iglesias-Gárriz 
Javier Inserte 
Carmen Jiménez 
Javier Jiménez-Candil 
Juan Jiménez-Jáimez 
Manuel Jiménez-Navarro 
Justo Juliá 
Alfonso Jurado-Román 
Adnan Kastrati 
Pablo Lázaro 
Pablo Loma-Osorio 
María López 
Esteban López-de-Sá 
Teresa López-Fernández 
José R. López-Mínguez 
Diego López-Otero 
Ramón López-Palop 
Gerard Loughlin 
Íñigo Lozano 
Begoña Manso 
Gerard Martí-Aguasca 
María Martín 
Isaac Martínez-Bendayán 
Sergio Martínez-Hervás 
M. del Mar Martínez-Quesada 
Efrén Martínez-Quintana 
Manuel Martínez-Sellés 
Lluís Masana 
Ana Méndez 
Irene Méndez 
Dolores Mesa-Rubio 
Emilio Monguió 
José M. Montero 
Silvia Montserrat 
Raúl Moreno 
Cesar Morís 
Luis Nombela 
Julio Núñez 
Raymundo Ocaranza 
Soledad Ojeda 
José M. Oliver 
Peter Ong 
Ana Osa 
Joaquín Osca 
Marta Pachón 
Teresa Padró 
Julián Palomino 
Manuel Pan 
Federico Paredes 
Isaac Pascual 
Domingo A. Pascual 
Rafael Peinado 
Pablo Peñafiel 
María L. Peña-Peña 
Leopoldo Pérez de Isla 
Armando Pérez de Prado 
Esther Pérez-David 
Jesús Peteiro 
Antonia Pijuan-Domènech 
Xavier Pintó 
Jesús Piqueras 
Susanna Prat 
Raquel Prieto 
Juan Quiles 
Sergio Raposeiras-Roubín 
Juan J. Ríos 
Fernando Rivero 
Ivo Roca-Luque 
Sergio Rodríguez de Leiras 
Luis Rodríguez-Padial 
Oriol Rodríguez 
Moisés Rodríguez-Mañero 
Ramón Rodríguez-Olivares 
José F. Rodríguez-Palomares 
Nieves Romero 
José Rozado 
Fernando Rueda 
Joaquín Rueda 
Ricardo Ruiz-Granell 
Juan M. Ruiz-Nodar 
Rafael Salguero 
Adriana Saltijeral 
José A. San Román 
Marianela Sánchez-Martínez 
Raúl Sánchez-Pérez 
Pedro L. Sánchez 
Violeta Sánchez 
Enrique Santas 
Gloria Santos 
Ricardo Sanz-Ruiz 
Fernando Sarnago 
Inés Sayago 
Alessandro Sionis 
Javier Suárez de Lezo 
José Suárez de Lezo 
Maite Subirana 
Antonio Tello-Montoliú 
Luis Teruel 
Jorge Toquero 
Aitor Uribarri 
Félix Valencia 
Israel Valverde 
Rafael Vidal 
Isidre Vilacosta 
Gemma Vilahur 
Fernando Worner 
Sergi Yun 
Carlos Zaragoza 
Esther Zorio 
Table 5.

Elite reviewers 2021

Fernando Alfonso 
Manuel Almendro 
Juan Caro-Codón 
Luciano Consuegra 
Alberto Cordero 
José M. de la Torre-Hernández 
José González-Costello 
Ramón López-Palop 
Julio Núñez 
José M. Oliver 
Aitor Uribarri 
OBJECTIVES FOR THE NEW ERAImpact factor

The IF is an imperfect metric of the quality of a journal but, whether we like it or not, it is one of the most commonly used parameters for judging a journal.35 We live in times of uncertainty regarding the formula used to calculate the IF. Thus far, to determine the numerator (citations received by published articles) and denominator (number of citable articles published), the formula has considered only articles published in an issue with their complete citation. The previous year saw the beginning of a transition that will, in the coming years, culminate in the counting of all articles published in their ahead of print (AOP) version instead of the final paginated version. It is not known when this change, which already impacted other journals in 2021, will fully affect Rev Esp Cardiol because the Web of Science, the database used to calculate the IF, does not currently index the AOP content of Rev Esp Cardiol but rather waits until the article is included in a specific issue, in contrast to other platforms such as MEDLINE and ScienceDirect. This is common for journals published by Elsevier, which benefited less from the general increase in the IF published in 2021. During this transition period, we will have to wait to assess the final situation of the IF of Rev Esp Cardiol when all of these changes stabilize. Nonetheless, beyond IF, the objective of a scientific and medical journal should be to publish high-quality articles that are relevant for clinicians and researchers.

Newsletters

Paralleling the transition toward the use of the AOP version to calculate the IF, the way that scientific content is accessed and consumed has been changing in recent years. Initially, the printed version was the main medium. Subsequently, the focus shifted to websites, where the user periodically reviewed the online content of the new issues. Currently, newsletters with the most recent AOP articles are the main method of dissemination. This approach facilitates the immediate release of information. Consequently, the focus of journals has moved to these newsletters, which is why one of the objectives of the new editorial team is their redesign. In this regard, the bilingual nature of the journal represents a further challenge. The articles accepted in Rev Esp Cardiol are available AOP in the original submission language and then in the translated version. The wait to have both versions available for their dissemination in the newsletter constitutes an excessive delay. However, dissemination when only the first version of the article is ready means that the translation is not simultaneously available and, in addition, that each newsletter would mix Spanish- and English-language articles. We will consider the advantages and disadvantages of all factors when studying all of the options to create the most attractive newsletter possible.

Publication times

The acceptance of an article is followed by 2 phases: a) from acceptance to publication of the AOP version; and b) from AOP publication to publication in an issue of Rev Esp Cardiol. In the first phase, we need to format and translate the article and apply the required corrections. This step takes about 2 months in each language, which means a total delay of 4 months until the AOP article is published in both languages. In the second phase, the publisher must prepare the article for its inclusion in an issue of Rev Esp Cardiol, which requires another 2 months. The issue of Rev Esp Cardiol in which the article will be published ultimately depends on the volume of articles awaiting publication. Thus, the actual time from the acceptance of an original article to its publication in a specific issue is 10 months. This delay has been falling in recent years due to the efforts of the editorial office, editors, and publisher. Our objective is to continue to reduce timelines, whenever it is possible to do so without compromising the excellent production quality of Rev Esp Cardiol. We believe that the critical period to shorten is the time from acceptance to AOP publication. The objective is to satisfy the general desire of authors to see their articles published as soon as possible, which is particularly important for articles reporting novelties.

Training in Rev Esp Cardiol

The current team of editors considers the educational role of Rev Esp Cardiol to be essential. It is a genuine challenge to reconcile this objective with IF metrics. Nonetheless, IF should not be the only parameter guiding the journal's strategy. In addition to continuing with the policy of the previous team of publishing special articles on topics of particular interest,31,36–42 we are beginning a partnership with the League of Clinical Cases of the Spanish Society of Cardiology43 to publish clinical cases, which will be accompanied by an editorial comment with a largely educational focus. In addition, we will attempt to entice residents and young cardiologists to conduct research and to write scientific articles through in-person or online courses or seminars focused on how to design a scientific project and write an article.

REC Publications family

In 2019, the REC Publications family of journals was created, which comprises Rev Esp Cardiol and 2 new journals, REC: Interventional Cardiology44 and REC: CardioClinics.45REC: Interventional Cardiology is focused on catheterization and interventional cardiology and their related heart diseases, whereas REC: CardioClinics addresses the entire cardiology spectrum.46,47 Both journals are currently in the difficult initial stages in which they are attempting to be indexed by the most important repositories. We must praise the tremendous efforts of their editorial teams in this launching phase. From this “Editor's page”, we would like to encourage authors to submit articles to both journals, either through direct submission or by accepting a transfer suggestion when an article unfortunately cannot be accepted in Rev Esp Cardiol. An overriding objective of Rev Esp Cardiol, and which we relay to all cardiologists, is to facilitate the submission of articles to REC: Interventional Cardiology and REC: CardioClinics as soon as possible.

In conclusion, in this first “Editor's page” of the new editorial team, we would like to express our enthusiasm for the new project and set as initial objectives the reimagining of newsletters, the optimization of publication times without compromising quality, the strengthening of the educational objectives of the journal, and the advancement of the REC Publications family. We hope that this project can count on your interest while also asking you for any suggestions that you might have.

FUNDING

None declared.

CONFLICTS OF INTEREST

None declared.

.

References
[1]
I. Ferreira-González, A. Sánchez-Recalde, E. Abu-Assib, M.A. Arias, P. Gallego.
A fond farewell from the editors of Revista Española de Cardiología 2015-2021.
Rev Esp Cardiol., 74 (2021), pp. 451-461
[2]
I. Ferreira-González, A. Sánchez-Recalde, E. Abu-Assib, M.A. Arias, P. Gallego, I. del Rio.
Revista Española de Cardiología: anuario de 2019.
Rev Esp Cardiol., 73 (2020), pp. 410-417
[3]
D. Vivas, I. Roldán, R. Ferrandis, et al.
Perioperative and periprocedural management of antithrombotic therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVE’ SECOT and AEU.
Rev Esp Cardiol., 71 (2018), pp. 553-564
[4]
J. Díaz-Gutiérrez, M. Ruiz-Canela, A. Gea, A. Fernández-Montero, M.A. Martínez-González.
Association between a healthy lifestyle score and the risk of cardiovascular disease in the SUN Cohort.
Rev Esp Cardiol., 71 (2018), pp. 1001-1009
[5]
A.B. Cid Álvarez, O. Rodríguez Leor, R. Moreno, A. Pérez de Prado.
Spanish Cardiac Catheterization and Coronary Intervention Registry 27th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2017).
Rev Esp Cardiol., 71 (2018), pp. 1036-1046
[6]
F.J. Garcia-Fernandez, J.L. Ibáñez-Criado, A. Quesada Dorador, et al.
Spanish Catheter Ablation Registry 17th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2017).
Rev Esp Cardiol., 71 (2018), pp. 941-951
[7]
E. Enríquez-Rodríguez, I.J. Amat-Santos, P. Jiménez-Quevedo, et al.
Comparison of the hemodynamic performance of the balloon-expandable SAPIEN 3 versus self-expandable Evolut R transcatheter valve: a case-matched study.
Rev Esp Cardiol., 71 (2018), pp. 735-742
[8]
F.J. Sangrós, J. Torrecilla, C. Giráldez-García, et al.
Association of general and abdominal obesity with hypertension, dyslipidemia and prediabetes in the PREDAPS Study.
Rev Esp Cardiol., 71 (2018), pp. 170-177
[9]
A. Perez-Castellanos, M. Martinez-Selles, M. Mejia-Renteria, et al.
Tako-tsubo syndrome in men: rare, but with poor prognosis.
Rev Esp Cardiol., 71 (2018), pp. 703-708
[10]
P. Díez-Villanueva, A. Ariza-Solé, M.T. Vidán, et al.
Recommendations of the Geriatric Cardiology Section of the Spanish Society of Cardiology for the assessment of frailty in elderly patients with heart disease.
Rev Esp Cardiol., 72 (2019), pp. 63-71
[11]
S.J. Na, C.R. Chung, Y.H. Cho, et al.
Vasoactive inotropic score as a predictor of mortality in adult patients with cardiogenic shock: medical therapy versus ECMO.
Rev Esp Cardiol., 72 (2019), pp. 40-47
[12]
A. Hernáez, M.D. Zomeño, I.R. Dégano, et al.
Excess weight in Spain: current situation, projections for 2030, and estimated direct extra cost for the Spanish Health System.
Rev Esp Cardiol., 72 (2019), pp. 916-924
[13]
P.I. Dorado-Diaz, J. Sampedro-Gómez, V. Vicente-Palacios, P.L. Sánchez.
Applications of artificial intelligence in cardiology The future is already here.
Rev Esp Cardiol., 72 (2019), pp. 1065-1075
[14]
C. Escobar, J. Martí-Almor, A. Pérez Cabeza, M.J. Martínez-Zapata.
Direct oral anticoagulants versus vitamin K antagonists in real-life patients with atrial fibrillation. A systematic review and meta-analysis.
Rev Esp Cardiol., 72 (2019), pp. 305-316
[15]
I. Ballesta García, J.A. Rubio Arias, D.J. Ramos Campo, I. Martínez González-Moro, M. Carrasco Poyatos.
High-intensity interval training dosage for heart failure and coronary artery disease cardiac rehabilitation. A systematic review and meta-analysis.
Rev Esp Cardiol., 72 (2019), pp. 233-243
[16]
E. Oliver, F. Mayr Jr., P. D’Ocon.
Beta-blockers: historical perspective and mechanisms of action.
Rev Esp Cardiol., 72 (2019), pp. 853-862
[17]
J. Sanchis, A. Ariza-Solé, E. Abu-Assi, et al.
Invasive versus conservative strategy in frail patients with NSTEMI: the MOSCA-FRAIL clinical trial study design.
Rev Esp Cardiol., 72 (2019), pp. 154-159
[18]
D. Vivas, V. Roldán, M.A. Esteve-Pastor, et al.
Recommendations on antithrombotic treatment during the COVID-19 pandemic Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology.
Rev Esp Cardiol., 73 (2020), pp. 749-757
[19]
C. Bonanad, S. García-Blas, J.F. Tarazona-Santabalbina, et al.
Coronavirus: the geriatric emergency of 2020 Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology.
Rev Esp Cardiol., 73 (2020), pp. 569-576
[20]
M.A. Rodríguez, I. Crespo, H. Olmedillas.
Exercising in times of COVID-19: what do experts recommend doing within four walls?.
Rev Esp Cardiol., 73 (2020), pp. 527-529
[21]
O. Rodríguez-Leor, B. Cid-Álvarez, Armando Pérez de Prado, et al.
Impact of COVID-19 on ST-segment elevation myocardial infarction care The Spanish experience.
Rev Esp Cardiol., 73 (2020), pp. 994-1002
[22]
J.R. Rey, J. Caro-Codón, D. Poveda Pineda, et al.
Arterial thrombotic complications in hospitalized patients with COVID-19.
Rev Esp Cardiol., 73 (2020), pp. 769-771
[23]
J. Aranceta-Bartrina, M. Gianzo-Citores, C. Pérez-Rodrigo.
Prevalence of overweight, obesity and abdominal obesity in the Spanish population aged 3 to 24 years The ENPE study.
Rev Esp Cardiol., 73 (2020), pp. 290-299
[24]
L. Laura Escolà-Vergé, M. Peghin, F. Givone, et al.
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study.
Rev Esp Cardiol., 73 (2020), pp. 711-717
[25]
C. Escobar, M. Manuel Anguita, V. Vicente Arrarte.
Recommendations to improve lipid control Consensus document of the Spanish Society of Cardiology.
Rev Esp Cardiol., 73 (2020), pp. 161-167
[26]
J. Bautista García, P. Peña Ortega, J.A. Bonilla Fernández, A. Cárdenes León, L. Ramírez Burgos, E. Caballero Dorta.
Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19.
Rev Esp Cardiol., 74 (2021), pp. 812-814
[27]
D. López-Otero, J. López-Pais, C.E. Cacho-Antonio, et al.
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population CARDIOVID registry.
Rev Esp Cardiol., 74 (2021), pp. 175-182
[28]
M. García-Guimaraes, T. Bastante, F. Macaya, et al.
Spontaneous coronary artery dissection in Spain: clinical and angiographic characteristics, management, and in-hospital events., 74 (2021), pp. 15-23
[29]
A. Calvo-Fernández, A. Izquierdo, I. Subirana, et al.
Markers of myocardial injury in the prediction of short-term COVID-19 prognosis.
Rev Esp Cardiol., 74 (2021), pp. 576-583
[30]
Á. López-Sainz, A. Hernandez-Hernandez, E. Gonzalez-Lopez, et al.
Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center.
Rev Esp Cardiol., 74 (2021), pp. 149-158
[31]
F. Loncaric, O. Camara, G. Piella, B. Bijnens.
Integration of artificial intelligence into clinical patient management: focus on cardiac imaging.
Rev Esp Cardiol., 74 (2021), pp. 72-80
[32]
R. Lorca, M. Jiménez-Blanco, J.M. García-Ruiz, et al.
Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart.
Rev Esp Cardiol., 74 (2021), pp. 870-877
[33]
B. Morentin, M.P. Suárez-Mier, A. Monzó, J. Ballesteros, P. Molina, J. Lucena.
Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases.
Rev Esp Cardiol., 74 (2021), pp. 225-232
[34]
M. Verdoia, E. Khedi, H. Suryapranata, G. De Luca.
Very short dual antiplatelet therapy after PCI and new DES: a meta-analysis of 5 randomized trials.
Rev Esp Cardiol., 74 (2021), pp. 140-148
[35]
V. Fuster.
Impact Factor: A curious and capricious metric.
J Am Coll Cardiol., 70 (2017), pp. 1530-1531
[36]
M.J. Page, J.E. McKenzie, P.M. Bossuy, et al.
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Rev Esp Cardiol., 74 (2021), pp. 790-799
[37]
R. Jean, J.R. Bragard, O. Camara, B. Echebarria, et al.
Cardiac computational modelling.
Rev Esp Cardiol., 74 (2021), pp. 65-71
[38]
S. Ravassa, A. González, A. Bayés-Genís, et al.
Myocardial interstitial fibrosis in the era of precision medicine Biomarker-based phenotyping for a personalized treatment.
Rev Esp Cardiol., 73 (2020), pp. 248-254
[39]
C. Baladrón, J.J. Gómez de Diego, A.J. Amat-Santos.
Big data and new information technology: what cardiologists need to know.
Rev Esp Cardiol., 74 (2021), pp. 81-89
[40]
J. De Backer, B. Callewaert, L. Muiño Mosquera, et al.
Genetics in congenital heart disease Are we ready for it?.
Rev Esp Cardiol., 73 (2020), pp. 937-947
[41]
A. Bayés de Luna, M. Martínez-Sellés, A. Bayés-Genís, et al.
What every clinician should know about Bayés síndrome.
Rev Esp Cardiol., 73 (2020), pp. 758-762
[42]
S.D. Slavin, H.J. Warraich.
The right time for palliative care in heart failure: a review of critical moments for palliative care intervention.
Rev Esp Cardiol., 73 (2020), pp. 78-83
[43]
Sociedad Española de Cardiología. Liga de los casos clínicos. Available in: https://ligacasosclinicos.com/. Consulted 14 Ene 2022.
[44]
REC: Interventional Cardiology. Available in: https://recintervcardiol.org/. Consulted 14 Ene 2022.
[45]
REC: CardioClinics. Available in: https://www.reccardioclinics.org/. Consulted 14 Ene 2022.
[46]
J.M. de la Torre-Hernández, F. Alfonso, J. Sanchis, R. Moreno.
REC: Interventional Cardiology in the COVID-19 year.
REC: Interv Cardiol., 3 (2021), pp. 239-244
[47]
S. Raposeiras-Roubín, L. Consuegra-Sánchez, A.J. Muñoz-García.
La consolidación de REC: CardioClinics.
REC CardioClinics., 56 (2021), pp. 129-134
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

View newsletter history
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?